Characteristics of Gut Microbiota in Rosacea Patients-A Cross-Sectional, Controlled Pilot Study.

Background: Recent studies have suggested a possible connection between rosacea and patients' gut microbiota.

Objective: To investigate the differences in fecal microbial profiles between patients with rosacea and healthy controls.

Methods: Gut microbiota of 54 rosacea patients (RP) were analyzed using MiSeq 16S rRNA sequencing. Enterotypes, the Firmicutes/Bacteroides (F/B) ratio, the significance of alpha and beta diversity, and differential abundance analysis (DAA) were calculated and compared with age- and gender-matched controls (CP, = 50).

Results: Significant changes in the enterotypes and F/B ratio were observed between the RP and CP ( = 0.017 and = 0.002, respectively). The RP showed a decreased microbial richness and diversity compared to the CP (Shannon = 0.012, inverse Simpson = 0.034). Beta diversity also differed between both groups (PERMANOVA, = 0.006). Fourteen significantly different taxa were detected according to DAA. (coef. -0.0800, = 0.008), sp. (coef. -0.073, < 0.001), and (coef. -0.072, = 0.015) were significantly decreased; sp. (coef. 0.023, = 0.031), (coef. 0.011, = 0.037), and (coef. 0.010, = 0.031) were significantly increased in the RP compared to the CP.

Conclusion: Significant alterations in gut microbiota were present in the RP. Taxonomic shifts and reduced richness and diversity were observed when compared to the CP. Larger prospective studies are needed to investigate correlations with clinical features and to translate these findings into future therapeutic approaches.